ArticlePloS one2025
Enhancing the dataset of CycleGAN-M and YOLOv8s-KEF for identifying apple leaf diseases.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate diagnosis of apple diseases is vital for tree health, yield improvement, and minimizing economic losses. This study introduces a deep learning-based model to tackle issues like limited datasets, small sample sizes, and low recognition accuracy in detecting apple leaf diseases. The approach begins with enhancing the CycleGAN-M network using a multi-scale attention mechanism to generate synthetic samples, improving model robustness and generalization by mitigating imbalances in disease-type representation. Next, an improved YOLOv8s-KEF model is introduced to overcome limitations in feature extraction, particularly for small lesions and complex textures in natural environments. The model's backbone replaces the standard C2f structure with C2f-KanConv, significantly enhancing disease recognition capabilities. Additionally, we optimize the detection head with Efficient Multi-Scale Convolution (EMS-Conv), improving the model's ability to detect small targets while maintaining robustness and generalization across diverse disease types and conditions. Incorporating Focal-EIoU further reduces missed and false detections, enhancing overall accuracy. The experiment results demonstrate that the YOLOv8s-KEF model achieves 95.0% in accuracy, 93.1% in recall, 95.8% in precision, and an F1-score of 94.5%. Compared to the original YOLOv8s model, the proposed model improves accuracy by 7.2%, precision by 6.5%, and F1-score by 5.0%, with only a modest 6MB increase in model size. Furthermore, compared to Faster RCNN, ResNet50, SSD, YOLOv3-tiny, YOLOv6, YOLOv9s, and YOLOv10m, our model demonstrates substantial improvements, with up to 30.2% higher precision and 18.0% greater accuracy. This study used CycleGAN-M and YOLOv8s-KEF methods to enhance the detection capability of apple leaf diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.